Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
Statistical Analysis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Casper, D.S.; Fleischman, A.N.; Papas, P.V.; Grossman, J.; Scuderi, G.R.; Lonner, J.H. Unicompartmental Knee Arthroplasty Provides Significantly Greater Improvement in Function than Total Knee Arthroplasty Despite Equivalent Satisfaction for Isolated Medial Compartment Osteoarthritis. J. Arthroplast. 2019, 34, 1611–1616. [Google Scholar] [CrossRef] [PubMed]
- Liu, L.; Li, J.; Wang, Y.; Li, X.; Han, P.; Li, X. Cemented versus cementless Oxford unicompartmental knee arthroplasty for the treatment of medial knee osteoarthritis: An updated systematic review and meta-analysis. Arch. Orthop. Trauma Surg. 2024, 144, 4391–4403. [Google Scholar] [CrossRef] [PubMed]
- Sutton, P.M.; Murray, J.S. The National Joint Registry 22 years on: What have we learned about knee replacements? Orthop. Trauma 2025, 39, 74–80. [Google Scholar] [CrossRef]
- Ryan, S.P.; Stambough, J.B.; Huddleston, J.I.; Levine, B.R. Highlights of the 2023 American Joint Replacement Registry Annual Report. Arthroplast. Today 2024, 26, 101325. [Google Scholar] [CrossRef]
- Johal, S.; Nakano, N.; Baxter, M.; Hujazi, I.; Pandit, H.; Khanduja, V. Unicompartmental Knee Arthroplasty: The Past, Current Controversies, and Future Perspectives. J. Knee Surg. 2018, 31, 992–998. [Google Scholar] [CrossRef]
- Zanirato, A.; Cavagnaro, L.; Chiarlone, F.; Quarto, E.; Formica, M. Periprosthetic joint infection in unicompartmental knee arthroplasty: Treatment options and outcomes. What is the current evidence in literature? Arch. Orthop. Trauma Surg. 2023, 143, 1031–1039. [Google Scholar] [CrossRef]
- Tay, M.L.; McGlashan, S.R.; Monk, A.P.; Young, S.W. Revision indications for medial unicompartmental knee arthroplasty: A systematic review. Arch. Orthop. Trauma Surg. 2022, 142, 301–314. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez, H.C.; Mekkawy, K.L.; Watkins, A.; Roche, M.W.; Burke, W.V.; Gosthe, R.G. Risk of Periprosthetic Joint Infection After Intra-Articular Corticosteroid Injection Following Unicompartmental Knee Arthroplasty. J. Arthroplast. 2023, 38, 815–819. [Google Scholar] [CrossRef]
- Lee, C.S.; Su, E.P.; Cross, M.B.; Carli, A.V.; Landy, D.C.; Chalmers, B.P. Unicompartmental Knee Arthroplasty Is Associated with a Lower Rate of Periprosthetic Joint Infection Compared to Total Knee Arthroplasty. Arthroplast. Today 2021, 10, 117–122. [Google Scholar] [CrossRef]
- Longo, U.G.; De Salvatore, S.; Bandini, B.; Lalli, A.; Barillà, B.; Budhiparama, N.C.; Lustig, S. Debridement, antibiotics, and implant retention (DAIR) for the early prosthetic joint infection of total knee and hip arthroplasties: A systematic review. J. ISAKOS 2024, 9, 62–70. [Google Scholar] [CrossRef]
- Weinstein, E.J.; Stephens-Shields, A.J.; Newcomb, C.W.; Silibovsky, R.; Nelson, C.L.; O’Donnell, J.A.; Glaser, L.J.; Hsieh, E.; Hanberg, J.S.; Tate, J.P.; et al. Incidence, Microbiological Studies, and Factors Associated with Prosthetic Joint Infection After Total Knee Arthroplasty. JAMA Netw. Open 2023, 6, e2340457. [Google Scholar] [CrossRef] [PubMed]
- McCormick, K.L.; Xu, W.; Cozzarelli, N.F.; Crawford, D.; Wilson, E.J.; Berend, K.R.; Fricka, K.B.; Lonner, J.H.; Geller, J.A. Debridement, Antibiotics, and Implant Retention in Unicompartmental Knee Arthroplasty Infection. J. Arthroplast. 2024, 39, S285–S289. [Google Scholar] [CrossRef]
- Asadollahi, S.; Hamilton, T.W.; Sabah, S.A.; Scarborough, M.; Price, A.J.; Gibbons, C.L.M.H.; Murray, D.W.; Alvand, A. The outcomes of acute periprosthetic joint infection following unicompartmental knee replacement managed with early debridement, Antibiotics, and implant retention. Knee 2024, 47, 13–20. [Google Scholar] [CrossRef] [PubMed]
- Fehring, T.K.; Fehring, K.A.; Hewlett, A.; Higuera, C.A.; Otero, J.E.; Tande, A.J. What’s New in Musculoskeletal Infection. JBJS 2020, 102, 1222–1229. [Google Scholar] [CrossRef] [PubMed]
- Petis, S.M.; Perry, K.I.; Mabry, T.M.; Hanssen, A.D.; Berry, D.J.; Abdel, M.P. Two-Stage Exchange Protocol for Periprosthetic Joint Infection Following Total Knee Arthroplasty in 245 Knees without Prior Treatment for Infection. JBJS 2019, 101, 239–249. [Google Scholar] [CrossRef]
- Hernandez, N.M.; Petis, S.M.; Hanssen, A.D.; Sierra, R.J.; Abdel, M.P.; Pagnano, M.W. Infection After Unicompartmental Knee Arthroplasty: A High Risk of Subsequent Complications. Clin. Orthop. Relat. Res. 2019, 477, 70–77. [Google Scholar] [CrossRef] [PubMed]
- Koch, K.A.; Weishorn, J.; Freytag, J.; Frey, P.E.; Hariri, M.; Merle, C.; Walker, T. Long-term outcome of periprosthetic joint infection following unicompartmental knee arthroplasty: A single-centre case series. J. Exp. Orthop. 2025, 12, e70230. [Google Scholar] [CrossRef]
- Qasim, S.N.; Swann, A.; Ashford, R. The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement—A literature review. SICOT J. 2017, 3, 2. [Google Scholar] [CrossRef]
- Marculescu, C.E.; Cantey, J.R. Polymicrobial prosthetic joint infections: Risk factors and outcome. Clin. Orthop. Relat. Res. 2008, 466, 1397–1404. [Google Scholar] [CrossRef]
- Cavagnaro, L.; Chiarlone, F.; Mosconi, L.; Zanirato, A.; Formica, M.; Burastero, G. Two-stage revision for periprosthetic joint infection in unicompartmental knee arthroplasty: Clinical and radiological results. Arch. Orthop. Trauma Surg. 2022, 142, 2031–2038. [Google Scholar] [CrossRef]
- Tsai, S.-W.; Mu, W.; Parvizi, J. Culture-negative periprosthetic joint infections: Do we have an issue? J. Clin. Orthop. Trauma 2024, 52, 102430. [Google Scholar] [CrossRef] [PubMed]
- Tan, T.L.; Kheir, M.M.; Shohat, N.; Tan, D.D.; Kheir, M.; Chen, C.; Parvizi, J. Culture-Negative Periprosthetic Joint Infection: An Update on What to Expect. JBJS Open Access 2018, 3, e0060. [Google Scholar] [CrossRef] [PubMed]
- Brivio, A.; Al-Jabri, T.; Martin, J.; Barrett, D.; Maffulli, N. Debridement, antibiotics and implant retention (DAIR) is successful in the management of acutely infected unicompartmental knee arthroplasty: A case series. Ann. Med. 2023, 55, 680–688. [Google Scholar] [CrossRef] [PubMed]
- Wignadasan, W.; Ibrahim, M.; Haddad, F.S. One- or two-stage reimplantation for infected total knee prosthesis? Orthop. Traumatol. Surg. Res. 2023, 109, 103453. [Google Scholar] [CrossRef]
- Kuiper, J.W.; Willink, R.T.; Moojen, D.J.; van den Bekerom, M.P.; Colen, S. Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts. World J. Orthop. 2014, 5, 667–676. [Google Scholar] [CrossRef]
- Zhu, M.F.; Kim, K.; Cavadino, A.; Coleman, B.; Munro, J.T.; Young, S.W. Success Rates of Debridement, Antibiotics, and Implant Retention in 230 Infected Total Knee Arthroplasties: Implications for Classification of Periprosthetic Joint Infection. J. Arthroplast. 2021, 36, 305–310.e1. [Google Scholar] [CrossRef]
- Parkinson, R.W.; Kay, P.R.; Rawal, A. A case for one-stage revision in infected total knee arthroplasty? Knee 2011, 18, 1–4. [Google Scholar] [CrossRef]
- Zhang, Y.; Gao, Z.; Zhang, T.; Dong, Y.; Sheng, Z.; Zhang, F.; Zhou, Y.; Guo, L. A comparsion study between debridement, antibiotics, and implant retention and two-stage revision total knee arthroplasty for the management of periprosthetic joint infection occurring within 12 weeks from index total knee arthroplasty. J. Orthop. Surg. Res. 2022, 17, 330. [Google Scholar] [CrossRef]
- Lazic, I.; Scheele, C.; Pohlig, F.; von Eisenhart-Rothe, R.; Suren, C. Treatment options in PJI—Is two-stage still gold standard? J. Orthop. 2021, 23, 180–184. [Google Scholar] [CrossRef]
- Del Arco, A.; Bertrand, M.L. The diagnosis of periprosthetic infection. Open Orthop. J. 2013, 7, 178–183. [Google Scholar] [CrossRef]
TKA (n = 71) | UKA (n = 11) | p-Value | |
---|---|---|---|
Age (years) | 67.7 ± 7.2 | 59.8 ± 7.0 | 0.004 a |
Gender | 0.520 b | ||
Female | 46 (64.8%) | 6 (54.5%) | |
Male | 25 (35.2%) | 5 (45.5%) | |
Operation side | 0.336 b | ||
Left | 39 (54.9%) | 3 (27.3%) | |
Right | 32 (45.1%) | 8 (72.7%) | |
Surgical Procedure | 0.002 b | ||
DAIR | 20 (28.2%) | 8 (72.7%) | |
Two-stage revision | 51 (71.8%) | 3 (27.3%) | |
Median Follow-up Time | 45 months | 49 months | 0.976 c |
(IQR) | (30–63) | (27–66) |
TKA (n = 71) | UKA (n = 11) | p-Value | |
---|---|---|---|
DAIR | 20 (28.2%) | 8 (72.7%) | 0.002 a |
No recurrence | 16 (80.0%) | 7 (87.5%) | |
Infection recurrence (required 2-stage revision) | 4 (20.0%) | 1 (12.5%) | |
Two-stage revision | 51 (71.8%) | 3 (27.3%) | 0.002 a |
No recurrence | 46 (90.2%) | 3 (100%) | |
Infection recurrence | 5 (9.8%) | 0 (0%) |
Microorganisms | TKA (n = 71) n (%) | UKA (n = 11) n (%) |
---|---|---|
Gram-positive microorganisms | ||
Staphylococcus aureus | 17 (25.3) | 6 (54.5) |
-MRSA | 9 (14.1) | 1 (9.1) |
Coagulase-negative staphylococci | 10 (14.1) | 3 (27.3) |
-MRCoNS | 9 (12.6) | 0 (0) |
Streptococcus spp. | 5 (7) | 0 (0) |
Enterococcus spp. | 3 (4.2) | 0 (0) |
Bacillus spp. | 1 (1.4) | 0 (0) |
Gram-negative microorganisms | ||
Enterobacteriaceae | ||
E. coli | 3 (4.2) | 0 (0) |
-ESBL producing | 2 (2.8) | 0 (0) |
Klebsiella spp. | 2 (2.8) | 0 (0) |
-ESBL producing | 1(1.4) | 0 (0) |
Serratia marcescens | 1 (1.4) | 0 (0) |
-ESBL producing | 1 (1.4) | 0 (0) |
Non-fermentative Gram-negative bacilli | ||
Pseudomonas aeruginosa | 2 (2.8) | 0 (0) |
Other | ||
Polymicrobial | 2 (2.8) | 0 (0) |
Culture Negative | 25 (33.8) | 2 (18.2) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nazlıgül, A.S.; Güven, Ş.; Erdoğan, Y.; Fırat, A.; Doğan, M.; Akkaya, M. Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes. Antibiotics 2025, 14, 585. https://doi.org/10.3390/antibiotics14060585
Nazlıgül AS, Güven Ş, Erdoğan Y, Fırat A, Doğan M, Akkaya M. Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes. Antibiotics. 2025; 14(6):585. https://doi.org/10.3390/antibiotics14060585
Chicago/Turabian StyleNazlıgül, Ali Said, Şahan Güven, Yasin Erdoğan, Ahmet Fırat, Metin Doğan, and Mustafa Akkaya. 2025. "Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes" Antibiotics 14, no. 6: 585. https://doi.org/10.3390/antibiotics14060585
APA StyleNazlıgül, A. S., Güven, Ş., Erdoğan, Y., Fırat, A., Doğan, M., & Akkaya, M. (2025). Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes. Antibiotics, 14(6), 585. https://doi.org/10.3390/antibiotics14060585